Neural Therapeutics Inc. Closes Rights Offering

Neural Therapeutics Inc. (Neural), a company specializing in the discovery and development of ethnobotanical drugs, has successfully completed its rights offering. The offering came to an end on July 7, 2023, resulting in the issuance of 5,595,992 common shares at a price of $0.03 per share. This generated a total of approximately $167,880 in gross proceeds for Neural. The funds raised from the ..